Mood State and Other Biomarkers: A Discovery-Based Approach
Alexander Niculescu, MD
Primary Investigator
Overview
The purpose of this study is to increase the knowledge of biomarkers of major psychiatric illnesses, such as bipolar disorder, depression, anxiety disorders, posttraumatic stress disorder (PTSD), schizoaffective disorder, schizophrenia, and related behaviors such as suicide.
Description
The purpose of the study is to increase the knowledge of major psychiatric illnesses, such as bipolar disorder, depression, schizophrenia, schizoaffective disorder, anxiety disorders, and post-traumatic stress disorder (PTSD), to understand the integration of clinicalpresentation, biomarkers, and genetics of these disorders, and related behaviors such as suicide
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Bipolar Disorder,Depression,Schizophrenia
-
Age: Between 21 Years - 65 Years
-
Gender: All
Inclusion Criteria
Male and females, ages 21-65
History of receiving treatment for bipolar disorder, depression, schizophrenia, schizoaffective disorder, or
Normal (non-psychiatric) controls.
Axis I diagnosis is not alcohol/drug induced.
Participant has not used any illegal drugs for at least 3 months prior to testing.
Exclusion Criteria
Younger, older, or other diagnoses other than those listed.
Current substance abuse, or past substance abuse as the primary diagnosis
Current neurological illness (Parkinson, Alzheimer, tumors), or past history of head trauma with loss of consciousness
